Addiction Treatment Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2030
Overview
The Addiction Treatment Market size was valued at USD 9.05 Billion in 2023 and the total Addiction Treatment Market size is expected to grow at a CAGR of 7.15 % from 2023 to 2030, reaching nearly USD 14.46 Billion in 2030.
Addiction is a mental health condition, that occurs when an individual consumes legal or illegal substances and is unable to control their use of drugs or other substances. Addiction treatment purposes to help patients limit their use of drugs. when an individual fails to discontinue the consumption of these drugs. The rising prevalence of substance abuse disorders, Increasing awareness of addiction and its treatment options, and government support for addiction treatment programs are the driving factors of the Addiction Treatment Market.
The report from Maximize Market Research presents a thorough analysis of the Addiction Treatment Market, focusing on expecting market growth trends and offering valuable insights into the supply chain dynamics. The market scope includes opportunities in new product development and advancements in drug formulation technologies, which drive market growth and innovation.
• According to MMR, about 32 million Americans aged 12 or older were addicted to drugs. Among them, about 27.6 million people used marijuana, 2.8 million people abused prescription pain relievers, and 1.9 million people used cocaine IN 2019.
Some of the major Key companies that are present in the addiction treatment systems market are Cipla Inc., Allergan, Alkermes, Pfizer Inc., Orexo AB, GlaxoSmithKline pic., Sandoz International GmbH, Reckitt Benckiser Group plc and other prominent players. These companies develop and manufacture medications used in addiction treatment,for Instance, methadone for opioid dependence or buprenorphine for opioid and alcohol use disorders.
Asia Pacific has been the fastest-growing region in the Addiction Treatment Market with a large market share of about 20.1 % in 2023 and is expected to grow at a CAGR of 7.15 % during the forecast period and maintain its dominance by 2030. The Asia Pacific region boasts a huge population, which includes a significant youth population. the addiction rates are on the rise in many parts of Asia Pacific. Factors like social pressures, economic anxieties, and easier access to substances contribute to this increase. with developing nations such as China and India experiencing an increase in substance addiction cases. With the growth of the market, there is a focus on providing cost-effective treatment choices to patients.
To know about the Research Methodology :- Request Free Sample Report
Addiction Treatment Market Dynamics:
Rising prevalence of addiction
The rising rates of addiction particularly to substances such as tobacco, alcohol, and drugs, have been a significant driver for the addiction treatment market. The rising rate of addiction occurred because of Various factors, including education, social and economic environment, the flexibility of healthcare systems and societies, as well as individual factors such as genetics, mental health, and trauma, all play a role in determining overall health.
There has been a significant rise in the number of people globally who are struggling with addiction to substances like alcohol, opioids, and stimulants Because of social pressures, mental health problems, and the easy availability of addictive substances. People with mental health conditions, such as depression, anxiety, or PTSD, often turn to these substances as a way of coping with their symptoms. The easily available substances including alcohol, tobacco, and illicit drugs, also contribute to addiction rates. For instance, the increasing availability and accessibility of opioids, both prescription and illicit, have led to a greater rise in opioid addiction and overdose deaths in the near future.
• Drug overdose deaths involving stimulants, cocaine, or psychostimulants with abuse potential (primarily methamphetamine) have significantly increased since 2015 from 12,122 to 53,495 in 2021.
Changes in drug policies, such as the legalization of cannabis in some regions and stricter regulations on opioid prescriptions, impact the dynamics of addiction treatment markets and outline demand patterns. Many Governments are investing more money in addiction treatment programs, supported by funding, policies because of addressing addiction and improving access to treatments are significantly driving the market, and The addiction treatment market is seeing a significant development with the growing demand for real-time data collection. This data is used to curate personalized treatment programs and streamline addiction treatment.
Lack of Physical and mental stability of patients during the treatment is hampering the market growth
The lack of physical and mental stability of patients hamper the effectiveness of addiction treatment programs. Patients struggling with addiction face difficulties in maintaining consistent engagement with treatment because of the withdrawal symptoms, cravings, and psychological challenges associated with substance dependence. It requires an individualized approach that considers the complex interplay of physical, mental, and emotional factors involved in addiction recovery.
Mental health issues and disorders, such as depression, anxiety, and trauma complicate the treatment process. these underlying mental health conditions are important for successful addiction treatment results. The uncertainty leads to non-compliance with treatment regimens, premature treatment discontinuation, and a higher risk of relapse.
• In February 2023, Sesh+, a smoking cessation company with the motive of preventing addiction and providing treatment, developed NRT products in flavors, such as cinnamon, pomegranate, and wintergreen, to enhance the adoption of treatment. The industry growth is being restrained by the relapse of addiction oues to the discontinuation of therapies.
Addiction Treatment Market Segment Analysis:
Based on the Treatment Type, the Tobacco/ Nicotine Addiction treatment segment helds the largest market share of about 34.01% in the Addiction Treatment Market in 2023. According to the MMR analysis, the segment is expected to grow at a CAGR of 9.02% during the forecast period and maintain its dominance till 2030. Tobacco/ Nicotine Addiction treatments are dominant because Tobacco use, particularly smoking remains a major global public health concern. High numbers of tobacco users and the active clinical trials of tobacco/nicotine addiction therapies. Ongoing research and innovation in treatment methods specific to tobacco and nicotine addiction contribute to growing the segments.
• According to MMR, there are over 1.3 billion tobacco users globally, with millions dying from tobacco-related diseases each year.
Nicotine replacement therapy (NRT) products like patches, gums, and lozenges are widely available over-the-counter, and prescription medications like varenicline are also an option. The availability makes it easier for people to seek help quitting. A growing public awareness about the dangers of tobacco use and the benefits of quitting. Public health campaigns, graphic warning labels on cigarette packs, and media coverage have all contributed shift. The increased awareness fuels the demand for cessation treatments as people become motivated to quit.
The alcohol segment is expected to register the fastest growth rate over the forecast period owing to its high consumption, easy availability, and heightened social acceptance, resulting in its increasing consumption globally
Based on the Treatment Centers, the outpatient treatment centers segment helds the largest market share in the Addiction Treatment Market in 2023 and is expected to maintain its dominance till 2030. outpatient treatment centers segment is dominating because allow individuals to maintain work, school, and family commitments while receiving addiction treatment. It is suitable for various levels of addiction recovery. Outpatient treatment is more likely to be covered by insurance compared to residential or inpatient programs, making it a more realistic option for many individuals. Outpatient treatment is more likely to be covered by insurance compared to residential or inpatient programs, making it a more realistic option for many individuals.
Addiction Treatment Market of Regional Analysis:
North America dominates the Addiction Treatment Market, which helds the largest market share accounting for 46.17% in 2023, the region is expected to grow during the forecast period and maintain its dominance by 2030. North America is a dominating region oues to the huge number of people who are addicted to substances like alcohol, tobacco, opioids, and others. increased consumption of illicit drugs, the penetration of insurance plans for costly diagnosis tests, and the region's significant revenue contribution to the market. Increasing drug awareness campaigns and prevention programs in North America have contributed to the growth of the addiction treatment market. These initiatives have helped to increase awareness about the negative effects of substance abuse, leading to a higher demand for addiction treatment services and products
• According to MMR, In 2023, around 14 out of every 100 adults aged 18 years or older in the United States smoked cigarettes, which accounts for 14.0% of the total adult population. Around 34.1 million adults in the US are currently smoking cigarettes, and an estimated 16 million people suffer from smoking-related illnesses and their associated effects. With such a significant population of smokers in the country, there is a growing demand for addiction treatments, which is driving the market growth for such treatments in the United States.
• The US has a well-developed medical system, which is supported by investment in research and efforts to control substance abuse. As a result, many Americans can access the necessary care they need. For example, in February 2022, Texas and some of its largest counties received $1.17 billion as part of a national settlement from three major drug distribution companies to help combat opioid addiction.
Europe represents a mature market for the Addiction Treatment industry, holding a market share of XX% and experiencing significant growth during its forecast period. Many European countries have high rates of addiction treatment compared to other regions. It represents a strong existing infrastructure and public awareness around addiction issues. Regulations about treatment modalities and insurance reimbursement for addiction treatment are well in Europe. So it limits the adoption of entirely new treatment methods.
Competitive Landscape for the Addiction Treatment Market:
A key Company's strategy is its constant commitment to research and development (R&D) to maintain a leading position in drug development. The competitive landscape of the Addiction Treatment Market includes a mix of established companies focusing on research and development to enhance efficiency and performance. Product launches have been an important strategic step for the major key players in the Addiction Treatment Market to remain competitive in the global market.
The market is characterized by technological advancements, government regulations, and consumer demand for products, driving the Addiction Treatment industry's growth.
• In June 2021, AELIS FARMA, a biotechnology organization working on the ailment of cerebrum issues, declared essential cooperation and choice permit concurrence with INDIVIOR PLC to address the serious results of weed use problems (CUD), including marijuana-prompted psychosis (CIP).
• In June 2021, Terveystalo Healthcare procured 72% of the shareholding in Feelgood Svenska AB and unveiled a suggested required deal of SEK 5.7/share.
• June 2021 - The Ridge is opening a new office that will provide comprehensive, private treatment for individuals suffering from drug and alcohol addiction.
• In 2022, Pfizer, Inc. announced a new strategic partnership with Alex Therapeutics to customize treatment through digital therapeutics and use AI-based platform of the latter company for providing Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) to patients of nicotine addiction.
• On 2022, Indivior PLC. entered into a collaborative agreement with Addex Therapeutics, a clinical-stage pharmaceutical company, for discovery and development of novel oral gamma-aminobutyric acid subtype B (GABAB) Positive Allosteric modulator (PAM) drug candidates. Under this agreement, Indivior will provide the latter company with round USD 900,000 as additional research funding.
Addiction Treatment Market Scope: Inquiry Before Buying
| Addiction Treatment Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 9.05 Bn. |
| Forecast Period 2024 to 2030 CAGR: | 7.15% | Market Size in 2030: | US $ 14.46 Bn. |
| Segments Covered: | by Treatment Type | Alcohol Addiction Treatment Tobacco/Nicotine Addiction Treatment Opioid Addiction Treatment Other Substance Addiction Treatment |
|
| by Drug Type | Bupropion Varenicline Acamprosate Disulfiram Others |
||
| by Treatment Centers | Outpatient Treatment Centers Residential Treatment Centers Inpatient Treatment Centers |
||
| by Distribution Channel | Hospital Pharmacies Medical Stores Others |
||
Addiction Treatment Market, by Region:
North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Russia, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, and the Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Addiction Treatment Market Key Players:
North America:
1. Pfizer Inc. (New York)
2. Alkermes Plc. (Ireland)
3. Titan Pharmaceuticals (California)
4. Indivor PLC. (U.S.)
5. Allergan (U.S)
6. Lupin Pharmaceuticals (U.S)
7. Mylan Laboratories (Pennsylvania)
8. Apotex (Canada)
9. Amphastar Pharmaceuticals (California)
10. Glenmark Pharmaceuticals (U.S.)
Europe:
1. GlaxoSmithKline Plc. (U.K.)
2. Teva Pharmaceuticals (Europe)
3. Hikma Pharmaceuticals (London)
4. Mallinckrodt (U.K.)
5. Orexo AB (Sweden)
6. Sanofi Aventis (France)
7. Reckitt Benckiser Pharmaceuticals (England)
Asia Pacific Region:
1. Cipla Ltd. (India)
2. Par Pharmaceuticals (India)
3. Sun Pharmaceuticals (India)
Frequently Asked Questions:
1] What is the growth rate of the Addiction Treatment Market?
Ans. The Addiction Treatment Market is expected to grow at a CAGR of 7.15 % during the forecast period of 2023 to 2030.
2] Which region is expected to hold the highest share of the Addiction Treatment Market?
Ans. North America is expected to hold the highest share of the Addiction Treatment Market.
3] What is the market size of the Addiction Treatment Market?
Ans. The Addiction Treatment Market size was valued at USD 9.05 billion in 2023 reaching nearly USD 14.46 billion in 2030.
4] What is the forecast period for the Addiction Treatment Market?
Ans. The forecast period for the Addiction Treatment Market is 2024-2030.
5] What segments are covered in the Addiction Treatment Market report?
Ans. The segments covered in the Addiction Treatment Market report are based on Treatment Type, Drug Type, Treatment Centres and Distribution Channels.